INTRODUCTION
Microorganisms were first recognized as a cause of disease more than a century ago by the pioneering laboratory work of Koch and Pasteur. From then until the present day, the microbiology laboratory has made significant contributions to the epidemiology of infectious diseases. Repeated isolation of a specific microorganism from patients with a given disease or syndrome helped prove infectious etiologies. Isolation and identification of microorganisms from animals, vectors, and environmental sources is invaluable in identifying reservoirs and verifying modes of transmission.
Despite remarkable scientific and technologic advances, outbreaks of infectious diseases still occur and new infectious diseases continue to emerge (1) . Many factors contribute to disease emergence (2) , and the epidemiology of many infectious diseases is becoming more complex. Fortunately, extremely sensitive and specific molecular techniques have recently been developed to facilitate epidemiologic studies. Nucleic acid amplification and analysis have emerged as particularly powerful analytic methodologies. These methodologies have prompted scientists to modify Koch's postulates as the standard of proof for a microbial etiology of a given disease (3) . In this review we use the terms nucleotide sequence, nucleic acid sequence, and gene sequence interchangeably but we recognize subtle distinctions. The respective terms all connote determinations of the sequence of nucleotides that comprise all or a portion of a microbial gene of interest.
MOLECULAR EPIDEMIOLOGY BY NUCLEIC ACID SEQUENCE ANALYSIS: PRINCIPLES OF THE APPROACH
During the course of bacterial evolution, genes that code for essential housekeeping molecules have remained highly conserved. For example, mutations of genes that code for proteins or RNAs whose function is constant and vital for the survival of bacteria occur at a much slower rate than those for genes that are under strong selective pressure, e.g., genes coding for surface proteins. Because medically relevant eubacteria have a common origin, molecular biologists can construct evolutionary (or phylogenetic) trees based on analyses of genes that code for these conserved macromolecules. The 16S ribosomal RNA (rRNA) gene has proved most useful in this regard and is considered a "molecular chronometer" that reflects the evolutionary distance between two bacteria over time (4) . At the operational level, the linear sequence of nucleotides that constitute the 16S rRNA gene is determined for a given bacterial species and compared with that of other species by one or more methods. An extensive catalog of bacterial 16S rRNA gene sequences exists in databases (e.g., GenBank), permitting rapid, comparative analysis of 16S rRNA gene sequences of various species of bacteria. In this fashion, previously characterized species of bacteria can be easily identified by genomic sequencing, and the phylogenetic position of new (and previously unsequenced) species can also be determined. Sequence analyses of other, variable genes that are unique to groups of bacteria are used to type strains and identify fine differences among isolates.
No equivalent, broadly conserved molecules exist among viruses, and so it is not possible to construct a single phylogenetic tree of all viruses. However, conserved and variable genes have been identified for numerous groups of viruses and provide a molecular basis for determining relatedness within the respective Molecular Epidemiology 91 groups. Genomic sequence analysis is of particular value in distinguishing closely related viruses.
Broad-range polymerase chain reaction (PCR) technology is a recently introduced, powerful technique for amplifying nucleic acids and has been used to detect and identify previously uncharacterized pathogens (5). For example, when conserved regions of the bacterial 16S rRNA gene are used to "prime" synthesis of the remainder of this gene, bacterial DNA can be detected and amplified directly from clinical samples that may contain small numbers of bacteria. The nucleotide sequence of the resulting PCR-amplified DNA can then be determined to identify variable regions of the 16S rRNA gene that are species specific. PCR-based gene sequencing has proven particularly valuable in identifying new, fastidious bacterial pathogens that have resisted cultivation and identification by traditional microbiologic methods. Because certain segments of the bacterial 16S rRNA gene are very conserved, one or more sets of primer pairs can be synthesized and used to amplify this gene from virtually all bacteria. Viral nucleic acids can also be detected and analyzed from clinical specimens, provided that investigators can successfully identify conserved sequences of nucleotides to serve as primers for a given group of viruses.
Genomic analysis is now widely used in research and in large clinical laboratories. Several examples follow, where PCR, coupled with nucleotide sequencing, have provided powerful tools for epidemiologic investigations of new and emerging diseases or identification of heretofore unknown pathogens.
DISEASE OUTBREAKS OF UNKNOWN ETIOLOGY: THE HANTAVIRUS INVESTIGATION
An outbreak of respiratory illness of unknown etiology occurred among previously healthy adults in the four-corners area of the United States in 1993 (6, 7) . The disease manifested as unexplained adult respiratory distress syndrome; the fatality rate in the first group of patients exceeded 75 percent (6) . Preliminary investigations revealed that patients' sera contained antibodies to hantavirus. These serologic findings were quite unexpected; although hantaviruses were well known as a cause of hemorrhagic fever with renal syndrome in Asia and Europe, they rarely had been associated with illness in the United States. Moreover, rodent reservoirs of known North American hantaviruses were extremely rare in the four-corners area.
Verification of the hantavirus etiology by virus isolation was potentially problematic because hantaviruses are notoriously difficult to cultivate, particularly from human tissues. However, because genomic sequence data were available for these viruses, hantavirus-specific primers were used in PCR reactions to detect and characterize hantavirus genetic material in specimens collected from adult respiratory distress syndrome patients and suspected reservoirs (6, 8) and to determine fundamental epidemiologic principles of the disease.
Tissues collected at autopsy were homogenized, and RNA was extracted by standard procedures; DNA copies of viral RNA (cDNA) were synthesized by using the enzyme reverse transcriptase. PCR amplification of the cDNA was then attempted, by using primers that were based on conserved nucleotide sequences of the glycoprotein-gene of the four bestcharacterized hantaviruses (Hantaan, Seoul, Puumula, and Prospect Hill viruses). Then, using a second set of primers internal to the first, another round of amplification was performed to increase sensitivity and specificity of nucleic acid detection (6, 8) .
Tissues from case-patients produced a DNA fragment of the expected length when Puumula-Prospect Hill primers were used, but DNA was not produced in response to Hantaan-Seoul primers. The nucleotide sequences of the gene fragments from patients were similar to those of Prospect Hill virus. However, sequences from patients were at least 30 percent different from all known hantaviruses, indicating that these adult respiratory distress syndrome cases had been caused by a novel hantavirus. Moreover, viral sequences derived from tissues of case-patients were approximately 7 percent different from each other, indicating that a new group of closely related hantaviruses caused this outbreak (6, 8) . The disease is now referred to as hantavirus pulmonary syndrome (7) .
Systematic trapping of rodents at case sites and in other parts of the four-corners area revealed the widespread prevalence of the deer mouse {Peromyscus maniculatus) (6, 8) . P. maniculatus had high (30 percent) rates of seropositivity to hantavirus antigens, especially Prospect Hill virus. When tissues from 61 seropositive P. maniculatus were tested by the PCR technique, using conserved nucleotide sequences of hantaviruses as primers, 59 (96.7 percent) were positive, suggesting that rodents are persistently infected with virus (8) . Comparison of nucleotide sequences of PCR products derived from patients and rodents verified that P. maniculatus was the likely source of infection. For example, viral nucleotide sequences derived from tissues of two case-patients in New Mexico were closely related but not identical. However, nucleotide sequences from the two case-patients were identical to those derived from P. maniculatus captured near their respective residences (6) . Presumably, humans became infected by inhaling virus in aerosolized rodent excreta.
Analysis of specimens from one adult respiratory distress syndrome patient was of particular interest. The patient lived in Colorado, but because he had traveled to Arizona immediately before the onset of illness, the source of his infection was uncertain. Nucleotide sequence analysis revealed that the hantavirus strain that had infected this patient was similar to that of other Colorado patients and genetically distinct from those in Arizona. Additionally, the patient's virus was identical to hantaviruses detected in rodents trapped near his home. Thus, infection most certainly was acquired near the patient's residence (5) .
A novel hantavirus (eventually called Sin Nombre virus) was isolated from lung tissue of P. maniculatus (9) and confirmed as an etiologic agent by serologic testing and genomic sequencing. Accumulating evidence indicates that a group of closely related hantaviruses exist throughout the United States and cause hantavirus pulmonary syndrome in humans (10, 11) . Apparently, each type of hantavirus has a different primary rodent reservoir. Genomic sequence analysis will be an invaluable tool for investigating the ecology and natural history of these viruses and for determining whether different viruses cause clinically distinct illnesses in humans.
DETECTION AND IDENTIFICATION OF BACTERIA RESISTANT TO CULTIVATION
The majority of bacterial infections are diagnosed clinically and confirmed by routine clinical microbiology laboratory methods, including isolation of the bacteria. However, many infectious diseases result from infections with highly fastidious bacteria and are not routinely confirmed by isolation. The procedures currently available to confirm infection by such fastidious bacteria are often laborious and timeconsuming, or occasionally even nonexistent. In the following examples, broad-range PCR, i.e., DNA amplification that uses highly conserved 16S rRNA gene sequences as primers, coupled with DNA sequencing, was instrumental in the initial detection and identification of pathogens. Once these microorganisms were identified, specific PCR primers were developed to facilitate epidemiologic studies of these diseases.
Whipple's disease
Whipple's disease is a systemic illness characterized by joint pain, abdominal pain, diarrhea, malabsorption, and weight loss. Diagnosis is usually made by observing bacilli within the intestinal lamina propria by electron microscopy or by light microscopy of tissues stained by periodic acid-Schiff. Since the original description of the disease almost 90 years ago (12) , and despite numerous attempts to cultivate this organism, no one has reproducibly cultivated or identified the Whipple's disease bacillus. However, in 1991, Wilson et al. (13) identified unique bacterial 16S rRNA gene sequences from a patient with Whipple's disease. Relman et al. (14) later confirmed the presence of this bacterial 16S rRNA gene sequence in five additional patients. They concluded that the Whipple's disease bacillus was a previously uncharacterized actinomycete; Tropheryma whippelii has been proposed as the name, but it remains an uncultivated species (14) . This organism has subsequently been detected in clinical specimens from patients with varied disease presentations (3). The natural habitat and full spectrum of disease caused by T. whippelii is not yet completely understood. Molecular tools will undoubtedly be used to answer these and other questions in the absence of techniques to culture this microorganism in the laboratory.
Bacillary angiomatosis/cat-scratch disease
Bacillary angiomatosis is observed primarily among patients with acquired immunodeficiency syndrome (AIDS); clinical manifestations include lesions of the skin and visceral organs. Macroscopically, lesions resemble those observed with Kaposi's sarcoma but are typified by vascular proliferation. Although bacillary angiomatosis was first described in 1983 (15), the etiology remained unclear until 1990. Using broadrange PCR primers, Relman et al. (16) detected and amplified segments of the bacterial 16S rRNA gene from the skin lesions of four patients with bacillary angiomatosis. The nucleotide sequences were identified as belonging to an unknown bacterium related to, but not identical to, Rochalimaea quintana, the etiologic agent of trench fever. Concurrently, R. quintanalike organisms were isolated independently from a number of other patients with varied clinical symptoms (17) . The latter isolates were subsequently shown to be a new species, Rochalimaea henselae, and identical to the agent causing bacillary angiomatosis (18, 19) . Gene amplification and nucleotide sequencing have been used in conjunction with bacterial isolation to study the epidemiology of bacillary angiomatosis and to identify potential reservoirs and vectors for the transmission of both R. henselae and R. quintana (20) .
Subsequent to these findings, R. henselae has been identified as the likely etiologic agent of cat-scratch disease. R. henselae 16S rRNA gene sequences were detected in the skin-test antigens that had been used for many years for the diagnosis of cat-scratch disease (21) . No other bacterial 16S rRNA gene sequences were detected in these preparations, indicating that the antigenic components of R. henselae are responsible for the delayed hypersensitivity that is observed with the cat-scratch disease skin test. Although cat-scratch disease was first described more than 40 years ago (22) , the bacterium that causes the disease had resisted detection and identification until it was studied by modern molecular techniques.
Broad-range PCR/nucleotide sequencing is currently being used to ascertain the role of cats and cat fleas in the transmission of Rochalimaea among patients infected with human immunodeficiency virus (HTV) (20) . Researchers have detected R. henselae in lymph-node tissue of cat-scratch disease patients with DNA probes specific for this microorganism, obviating the need for nucleotide sequencing (23) . Although these techniques are not practical for most clinical laboratories, they are more sensitive than isolation and more specific than serologic assays for the diagnosis of cat-scratch disease. However, serology remains the most convenient technique for laboratory confirmation of this disease.
Ehrlichiosis
Ehrlichiae are obligate intracellular bacteria that are related to the rickettsiae. They preferentially infect leukocytes of host mammals. Until the 1980s, most species were presumed to be pathogenic for domestic animals but not humans. In 1987, Maeda et al. (24) described a patient with a history of tick bite who developed symptoms similar to those observed in persons with Rocky Mountain spotted fever. Electron microscopy of peripheral blood revealed intracellular inclusions characteristic of the genus Ehrlichia within the patient's monocytes. Ehrlichia canis was presumed to be the causative agent of this disease, based on serologic reactivity of this patient's serum with E. canis antigen. This conclusion seemed implausible, however, because E. canis was a well-known pathogen of canines that previously had not caused documented infections in humans.
Subsequently, the 16S rRNA gene sequence of the infectious agent was determined by broad-range PCR amplification of DNA extracted from peripheral blood leukocytes of two other patients who developed ehrlichiosis. The nucleotide sequences derived from the two patients were identical but different from all existing species of Ehrlichia, including E. canis (25) . The same sequence was also identified in an isolate that was subsequently obtained from one of these two patients (26) . Because the genetic divergence of this isolate from other species of Ehrlichia was greater than for existing species in the genus (table 1), it was designated as a new species, Ehrlichia chqffeensis. PCR primers specific for E. chaffeensis have subsequently been developed and used to detect microorganisms in potential tick vectors; Amblyomma americanum has been implicated as a possible vector for the transmission of E. chaffeensis (27) . Detection of ehrlichiae by molecular techniques is quite useful because pathogenic ehrlichiae have proven difficult to cultivate in the laboratory.
Broad-range PCR/sequencing has also identified the etiologic agent of another form of human ehrlichiosis. Recently, two fatal cases occurred in a cluster of patients suffering from ehrlichiosis-like symptoms (fever, headache, myalgia, leukopenia, and thrombocytopenia). However, in contrast to typical cases of ehrlichiosis where the characteristic ehrlichial inclusions are found in peripheral blood monocytes, ehrlichiae were observed in patient's granulocytes. DNA was extracted from peripheral blood cells of these patients and subjected to broad-range PCR-based sequence analysis. The results indicated that patients had been infected with a species of Ehrlichia not previously associated with human disease, Ehrlichia phagocytophila (28) .
Molecular approaches offer the epidemiologist the opportunity to implicate agents, vectors, and sources * Sequences were aligned in a pairwise fashion using the "Gap" program of the Genetics Computer Group package (46) . t Accession numbers of the sequences used for alignment are indicated in parentheses.
Epidemiol Rev Vol. 18, No. 1, 1996 of infection in the disease process in the absence of a pure culture. Although this may seem contrary to the principles of Koch's postulates, the use of molecular techniques to identify infectious etiologies is gaining widespread acceptance. The specific detection of microbes in a significant number of representative patient specimens provides compelling evidence of their role as etiologic agents. Recently, Fredricks and Relman (3) described various approaches that utilize sequencebased technology to detect, identify, and associate an etiologic role for various microorganisms. Figure 1 summarizes these approaches. Additional details and applications of this approach are described elsewhere (29) (30) (31) (32) .
ESTABLISHING UNUSUAL MODES OF DISEASE TRANSMISSION: HIV AND DENTISTS
The power of molecular techniques in epidemiologic investigations is well exemplified by a study of HIV transmission by a health-care worker. The investigation centered on a young woman who had contracted AIDS even though she had no identifiable risk factors. Preliminary investigations revealed that 2 years previously she had several teeth extracted by a dentist who was subsequently confirmed as having AIDS. A retrospective case-control study was conducted of the dentist and his former patients to evaluate the possibility of dentist-to-patient transmission. Patients were queried to ascertain known risk factors for HIV. Infection control practices in the dental office were also evaluated (33) . Partial nucleotide sequences were determined for HIV strains of patients and controls as part of the investigation (34) . HIV genomes were analyzed by several different techniques to ensure the validity of findings. Eight HIV-positive persons were identified from among a group of more than 1,000 former patients of the dentist. Five of the eight patients had no risk factors or other documented exposures to HIV. Although all five had received invasive procedures, and four of the five had shared visit days, no identifiable mechanism of transmission could be established by traditional case-control methodology (33) . However, genomic sequencing of HIV strains established the likelihood of a common source of infection. By using PCR technology, sequence analysis was performed on regions of the gp 120 gene of HIV virus from the dentist, HIV-positive patients, and 35 HIV-infected persons from the local community (controls). The genetic distance of viruses from the five patients without known risk factors and virus from the dentist was 3.4 to 4.9 percent; this distance is similar to that found previously with HIV viruses obtained from persons with epidemiologically linked infections. In contrast, isolates from the patients with identifiable risk factors were more distantly related (greater than 10 percent) to HIV virus obtained from the dentist (34) . Additionally, the average genetic distance of viruses from the five patients and locally acquired controls was approximately 11 percent, which was virtually identical to the average distance among the 35 HIV viruses from controls. Phylogenetic tree analysis confirmed that HIV viruses from the five patients and the dentist formed a tightly related cluster (34).
Apparently, dentist-to-patient transmission of HIV is extremely rare. In a similar but unrelated study (35) , phylogenetic tree analysis of an HTV-infected dentist and 24 HIV-positive patients failed to implicate the dentist as the source of infection. Consistent with the genetic analyses, most of the patients in this study had identifiable risk factors for acquiring HIV infection.
VERIFYING UNUSUALLY LONG INCUBATION PERIODS IN RABIES INFECTIONS
Occasionally, cases of human rabies occur in which the history of exposure cannot be documented. Molecular techniques now allow such a determination. Smith et al. (36) investigated three cases of human rabies among immigrants who lived in areas of the United States where animal rabies is either extremely rare or nonexistent. Although no animal contact could be documented in the United States, dog bite was documented in the country of origin 6 and 7 years previously for two of the three patients. The third patient had emigrated 1 year before from a country where dog rabies was also endemic. Isolates of rabies virus were obtained from all three patients and compared by several methods with human and animal isolates that had been acquired from various geographic regions, including areas from which the three patients had emigrated. Dog isolates from the country or region of origin of the three patients were included in the analyses. cDNA copies of viral RNA were prepared and amplified by PCR; DNA was then cleaved by restriction endonucleases and the fragments separated by agarose gel electrophoresis. The electrophoretic pattern that was obtained with the three human isolates corresponded exactly to the pattern obtained with dogs isolates from their respective countries or areas of origin, and were distinct from viruses in the states where they resided. Although long incubation rabies has been reported several times, it could never be confirmed. The molecular techniques used in this study allowed the first confirmation of this unusual phenomenon. Other applications are certain to follow.
PALEOMICROBIOLOGY
Human T-cell lymphotropic virus type I (HTLV-I) is a well-known human retrovirus that causes adult T-cell leukemia/lymphoma. Simian T-cell lymphotropic virus is a related virus found in nonhuman primates. With both viruses, proviral DNA is incorporated into the host genome. Detecting this DNA in peripheral blood cells of the patient can establish a clinical diagnosis.
The origin of HTLV-I and other retroviruses has been the subject of considerable speculation. Available genomic sequencing data suggests that two types of HTLV-I isolates exist: so-called cosmopolitan isolates, which have been acquired in Japan, the Americas, Africa, and the Caribbean and have more than 97 percent nucleotide sequence similarity; and AustraloMelanesian variants (from New Guinea, Australia, and the Solomon Islands) which by gene sequencing anal-ysis are approximately 7 percent divergent from cosmopolitan strains. The concept of separate origins for these two groups of viruses contrasts with the prevailing opinion that all strains of HTLV-I originated from a common progenitor virus in Africa, possibly human T-cell lymphotropic virus type II (HTLV-II).
To determine whether cosmopolitan and AustraloMelanesian isolates of HTLV-I might have originated separately, Nerurkar et al. (37) developed and evaluated phylogenetic trees based on genomic sequence analysis of the env gene of HTLV-I isolates. First, these researchers prepared DNA from cells infected with HTLV-I and Simian T-cell lymphotropic virus isolates that had originated in widely diverse geographic areas. Included were three isolates from Papua New Guinea, nine from the Solomon Islands, one from an aboriginal Australian, and 23 other human and simian isolates from around the world. Next, primers specific for the gp 46-and gp 21-encoding regions of the env gene of HTLV-I strains from Melanesia were used to amplify retroviral DNA from the respective viruses by PCR. Only HTLV-I strains originating from Melanesians of Papua New Guinea and the Solomon Islands and from the aboriginal Australian were amplified with these primers.
The nucleotide sequence of the env gene was then determined for each Australo-Melanesian isolate and compared with corresponding sequences of several HTLV-I and Simian T-cell lymphotropic virus strains, the latter being available from gene sequence databanks (GenBank). Comparison of nucleotide sequences confirmed that Australo-Melanesian isolates of HTLV-I were distinct from cosmopolitan strains, and formed a group of geographically distinct genotypes of separate origin.
These findings contest the popular belief that all strains of HTLV-I originated in Africa. Nerurkar et al. (37) speculate that ancestors of the current AustraloMelanesian strains originated thousands of years ago in Sunda, the ancient Southeast Asian landmass, as a result of interspecies (human and nonhuman primate) transmission of lymphotropic retroviruses and that they evolved independently of other HTLV-I viruses. Presumably, the original Australo-Melanesian viruses became distributed throughout the Western Pacific region as a result of migrations during the succeeding millennia. The fact that the HTLV-I isolates used in this study originated from aboriginal Australian and Melanesian populations who are geographically isolated and have had no contact with Africans or the Japanese supports their hypothesis.
Determining the origins of microorganisms is certainly of much more than academic interest. Better understanding of the origins and natural history of pathogenic microorganisms allows informed speculation as to the likelihood of similar events in the future, and prediction of evolutionary trends. Similar studies are being conducted by others (38) (39) (40) (41) . Typically, analyses of variable and conserved genes are both performed to provide answers to recent changes and long-term trends, respectively.
EPILOGUE
This brief review has focused primarily on gene amplification and nucleic acid sequencing as epidemiologic tools; numerous other molecular techniques are available and have been used successfully (42) . Molecular techniques are used primarily to distinguish closely related microorganisms and to document patterns of transmission of strains and species within populations. Ideally, molecular epidemiologic techniques should also allow determinations of why infections occur and if they are likely to occur in the future. Techniques that utilize virulence markers of microorganisms and susceptibility markers of human populations are needed to provide such determinations. For example, ligands and receptors that mediate the attachment of microorganisms to the surface of host cells are being described at the molecular level (43) . Similarly, processes associated with the invasion of tissues by microorganisms and dissemination within the host are also being investigated (44) . These molecules may provide the basis for development of newer techniques.
Studies of recurrent candidiasis in women provide an example of this approach to epidemiologic investigations. Attachment of Candida species to mammalian cells occurs when the mannoprotein of the candidal cell wall reacts with carbohydrate receptors on the host cell membrane, particularly carbohydrates that comprise blood group antigens. Epidemiologic investigations have revealed a significant association of recurrent candidal vaginitis in women with Lewis group phenotype Le *~b~t suggesting that certain variants of Candida albicans preferentially or exclusively infect these women (45) . Investigators hypothesize that the composition of carbohydrates comprising the blood group antigens molecules, especially Af-acetyl glucosamine and fucose, determine which strains will attach and invade a particular person. Similar investigative approaches are needed to refine definitions of microbial and host populations and to better understand the epidemiology of infectious diseases.
